Michael G. Fradley

机构：University College Hospital, Hospital of the University of Pennsylvania, California University of Pennsylvania, University College London, University of Pennsylvania · ORCID：0000-0001-8352-8975

发表论文 269 篇 · 总被引 14298 次 · h-index 44

代表论文

• Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects (2025 · JAMA Oncology · 被引 25)
• Considerations for the practical management of cardiovascular risk with Bruton’s tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia (2025 · The Oncologist · 被引 13)
• Real-world analysis of cardiovascular adverse events and risk factors after immune checkpoint inhibitor therapy (2025 · Cardio-Oncology · 被引 4)
• New-onset atrial fibrillation as a predictor of cancer: Insights from a real-world dataset (2025 · Heart Rhythm · 被引 3)
• Contemporary management of atrial fibrillation in patients with cancer—the 2025 European Heart Rhythm Association survey (2026 · EP Europace · 被引 2)
• Sarcoma: Cardiovascular and Oncologic Considerations (2025 · JACC CardioOncology · 被引 2)